PathoFinder, founded in 2004, develops and manufactures comprehensive molecular diagnostic assays for pathogens causing an infectious disease. Our proprietary multiplex PCR technologies enable syndromic-based diagnostics.
PathoNostics, founded in 2011, is PathoFinder’s sister company and is focusing on the development and manufacturing of assays for fungal diagnostics.
Products of both PathoFinder and PathoNostics are designed to work on commercially available detection platforms.